Atea showcased its Phase III HCV programme at JPM for bemnifosbuvir/ruzasvir, positioning the regimen for test-and-treat ...
In a cohort of young adults with metastatic colorectal cancer (mCRC), 3-year survival was lowest among Black patients and ...
18h
Glioblastoma Multiforme Treatment Market to Worth Over US$ 6.1 Billion by 2033 | Astute Analytica
Rising incidence rates, high recurrence, and limited curative options are accelerating demand for innovative glioblastoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback